Billions Co.,Ltd. (KOSDAQ:044480)
South Korea · Delayed Price · Currency is KRW 332.00
+6.00 (1.84%)
At close: Apr 2, 2026
Billions Revenue
In the year 2025, Billions had annual revenue of 25.31B KRW, down -39.34%. Billions had revenue of 5.11B in the quarter ending December 31, 2025, a decrease of -51.38%.
Revenue
25.31B
Revenue Growth
-39.34%
P/S Ratio
1.06
Revenue / Employee
284.38M
Employees
89
Market Cap
26.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 25.31B | -16.42B | -39.34% |
| Dec 31, 2024 | 41.72B | 12.74B | 43.94% |
| Dec 31, 2023 | 28.99B | -41.66B | -58.97% |
| Dec 31, 2022 | 70.65B | 44.88B | 174.22% |
| Dec 31, 2021 | 25.76B | 12.71B | 97.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 135.41B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 63.66B |
| OSTEONIC | 45.39B |
| Wonbiogen | 34.38B |
| SCL Science | 16.32B |
| MEDYSSEY Co.,Ltd | 10.60B |
| Plasmapp | 8.48B |